EIAs for IgG and IgM antibodies directed against Ebola (EBO) viral antigens have been developed and evaluated using sera of animals and humans surviving infection with EBO viruses. The IgM capture assay detected anti-EBO (subtype Reston) antibodies in the sera of 5 of 5 experimentally infected animals at the time they succumbed to lethal infections. IgM antibodies were also detected in the serum of a human who was infected with EBO (subtype Reston) during a postmortem examination of an infected monkey. The antibody was detectable as early as day 6 after infection in experimentally infected animals and persisted for õ90 days. The IgG response was less rapid; however, it persisted for ú400 days in 3 animals who survived infection, and it persisted for Ç10 years after infection in the sera of 2 humans. Although these data are limited by the number of sera available for verification, the IgM assay seems to have great promise as a diagnostic tool. Furthermore the long-term persistence of the IgG antibodies measured by this test strongly suggests that the ELISA will be useful in field investigations of EBO virus.
The ecology and epidemiology of Ebola (EBO) virus subelectrophoresis and transferred to a paper medium) [19] . ELISA and RIA are procedures that have been used commonly for the types have been the topic of considerable study since the occurrence of high-mortality EBO epidemics [1 -3] . Such studies screening of antibodies to other viral diseases; however, they have not been commonly applied in filovirus research, and their have been hampered by the lack of effective serologic tools with which to survey for individuals, populations, or other practical value remains largely unevaluated. The RIPA and the Western blot measure antibody responses to individual viral vertebrate hosts with specific serologic evidence of past infection. The indirect fluorescent antibody test (IFAT) [4, 5] has proteins in slightly different ways and offer the advantage of showing the molecular specificity of the response; however, been the most commonly used serologic technique for EBO virus serology. It has shown good sensitivity for antibodies both techniques are most commonly used as confirmatory or research tools to dissect the immune response -the tests are during early convalescence and has been used extensively in serologic surveys for EBO virus antibody prevalence [6 -14] ; too cumbersome to be used as primary serologic tools in studies of an epidemiologic scale. however, it has been criticized for a perceived lack of specificity in populations with no apparent probability of infection
The duration of antibodies measured by serologic tests used for epidemiologic studies is a central question in their use: with the African filoviruses [15] and because of an inability to confirm its results with those of other immunologic techniques How rapidly do antibodies become detectable and how long do they remain measurable? The rapid decline of IFAT antibod- [16] .
Other serologic tests for EBO viral antibody have been deies in persons infected with EBO virus has been reported [2] ; however, the use of the various tests (including the IFAT) on scribed: They include ELISA [17] , RIA [18] , RIPA (radioimmunoprecipitation assay), and Western blot analysis (immunosera documented to be from genuine cases is limited, thus handicapping (for epidemiologic purposes) the interpretation assay of viral proteins separated by polyacrylamide gel of results from existing serologic tests for filoviruses.
Herein, we present the use of an ELISA test for both IgG and IgM antibodies. We also present data that support the sensitivity and longevity of these tests in a limited number of In conducting the research described in this report, the investigator(s) adhered to the ''Guide for the Care and Use of Laboratory Animals,'' as promulexperimentally infected primates and humans who survived The views of the author(s) do not purport to reflect the positions of the MRC5 / 1, Vero / 2, suckling mouse brain / 1, Vero / 1, CV7 infected and uninfected (30%:70%) cells was put on 12-spot Teflon-coated slides, dried, fixed in acetone, and stored at 070ЊC / 1); and EBO (subtype Reston [EBO-R], strain H28; passage: MA104 / 4, CV7 / 1). In brief, MA104 cells in roller bottles until used. Sera (2-fold dilutions) were incubated in the wells of the slides for 30 min at 37ЊC in a humidified container and then were infected with EBO virus strains and allowed to proceed until advanced cytopathic effect was observed. Cells remaining attached washed in PBS followed by distilled water for 10 min each. Bound anti-EBO antibodies were detected by anti-human IgG fluoresceinto the walls of the roller bottles were scraped free with a rubber policeman, and cells and supernatant were separated by centrifugalabeled rabbit anti-human conjugate for 30 min at 37ЊC in a humidified container. After a final wash, the coverslips were mounted tion (10,000 g) at 4ЊC for 10 min. Cells were washed once in 0.01 M borate saline, pH 9.0, and pelleted as above. The cell pellet was with glycerol-PBS (50:50), and the slides were read by use of a fluorescent microscope with appropriate barrier and excitation filresuspended with a vortex in borate saline, pH 9.0, with 1% (vol/ vol) Triton X-100 (Sigma, St. Louis) in a polycarbonate Oak Ridge ters for fluorescein isothiocyanate visualization. tube (Nalge, Rochester, NY). The resuspended pellet was then sonicated in a chilled cup horn for 10 min, with the device set at a 50% duty cycle. This sonicated suspension was centrifuged at ELISA Procedures 10,000 g for 5 min at 4ЊC, and the supernatant was collected as General procedures. All reagents were added to wells of polystated above for the antigen. The supernatant was gamma-irradivinyl chloride microtiter plates (Dynatech, Vienna, VA) in 100-ated with 2 1 10 6 rad (20,000 Gy) to ensure virus inactivation mL volumes. Antigens and antibodies were adsorbed to wells after (repeated infectivity tests have shown complete inactivation of the dilution in 0.01 M PBS, pH 7.4, and adsorbed overnight. Wash preparation due to the combined effect of the detergent and the buffer was comprised of PBS with 0.1% (vol/vol) Tween 20 (Bioirradiation). Following irradiation, the antigen was aliquoted into Rad, Richmond, CA) (PBS-T). All subsequent serum and reagent small portions and stored at 020ЊC until used. Uninfected MA104 dilutions were in 5% nonfat milk (Difco, Detroit) in PBS-T. Incucells were similarly prepared and used as a control or comparison bations, except for substrate, were done for 60 min at 37ЊC in a antigen.
humid chamber; between reagent steps, plates were washed 3 times Viral antigens for the IgM test were made by centrifuging with PBS-T. Substrate was H 2 O 2 -ABTS (Kirkegaard & Perry, (25,000 g at 4ЊC) infected supernatant from infected CV7 cell Gaithersburg, MD). Plates with substrate were incubated for 30 cultures for 120 min. The virus pellet was resuspended in 0.01 M min in a humid chamber at 37ЊC before the plates were read PBS, pH 7.4, of about a 100th of the original volume from which spectrophotometrically and optical density (OD) values at 410 nm it had been spun, gamma-irradiated with 5 1 10 6 rad (50,000 Gy), were captured on a microcomputer. Adjusted OD values at 410 and safety tested for residual virus infectivity.
nm were computed using a commercial spreadsheet package (Lotus 123; Lotus, Cambridge, MA).
Sera
IgG ELISA. The IgG ELISA was performed by coating the plate directly with the basic buffer detergent extract described The sera of animals infected experimentally with the EBO-R above. Dilutions of antigens used to coat polyvinyl chloride microvirus [20] were used for IgG and IgM tests. Two of the animals titer plates were determined by checkerboard titration with referwere Macaca mulatta that had been infected with a virus seed ence sera. In this instance, antigens for EBO-R, EBO-S, and EBOinadvertently contaminated with simian hemorrhagic fever virus Z were diluted 1:1000 in PBS, and 0.1 mL was adsorbed to the (SHFV); however, both animals were also clearly infected with microtiter plates overnight at 4ЊC. An uninfected MA104 cell cul-EBO-R. The third animal, a Macaca fascicularis, was infected ture antigen was also coated to plates and used to determine the with another isolate (H28) of EBO-R that was not contaminated specific binding of antibody to viral antigens. Antigen was rewith SHFV. Periodic blood sampling and separation of serum were moved from the wells by washing 3 times with PBS-T. Sera were performed over the ensuing 400/ days. Sera from 548 primates diluted 1:100 and 4-fold through 1:6400 in 5% nonfat milk in who were imported under quarantine requirements with no evi-PBS-T and allowed to react with the antigen-coated wells. Bound dence of active filoviral infection were also tested by IFAT and IgG was detected with mouse anti-human IgG (g-chain specific; IgG ELISA.
Accurate Chemical, Westbury, NY) conjugated to horseradish perHuman sera were from an animal handler who had become oxidase. ODs at 410 nm were recorded on a microplate spectrophoinfected during the 1989-1990 epizootic in a quarantine facility tometer, and the OD of the uninfected antigen-coated well was [20, 21] or from persons who survived either laboratory [22] or subtracted from its corresponding viral antigen-coated well to field infections [23] with EBO-Z.
yield the adjusted OD at 410 nm. A panel of 5 to 6 normal sera are run each time the assay was used. The mean and SD of the value of the adjusted ODs were accumulated and used to calculate IFAT Procedures a value equal to the mean / 3 SD. This represents the cutoff value for the assay and is usually about an OD (at 410 nm) of 0.2 at a The procedure was done as previously described with some small modifications [4] . EBO-infected and uninfected Vero cells 1:100 dilution. IgM capture ELISA. A virus-specific IgM test was done by were prepared in a biosafety level 4 laboratory, washed in PBS, and resuspended in a freezing medium (Eagle MEM with Earle's capturing the IgM from the serum with goat anti-human antibody (m-chain specific; Tago, Burlingame, CA) adsorbed to the wells salts and 10% fetal calf serum plus 5% DMSO). The frozen cell suspensions were inactivated with gamma irradiation (5 1 10 6 rads of the microtiter plates and then allowing the captured IgM to react with viral antigen [24] . Captured viral antigen was detected [50,000 Gy]) to allow for safe handling. A PBS suspension of shown in figure 2 , the antibody levels to the homologous EBOBound anti-EBO antibodies were detected by anti-mouse IgG R strain appeared to be consistently higher during early conva-(heavy and light chain specific; Boehringer Mannheim, Indianapolescence. However, with time, the antibody levels became aplis) conjugated to horseradish peroxidase, followed by H 2 O 2 -ABTS proximately equivalent for antigens of all 3 strains of EBO substrate. A negative CV7 cell antigen was used to adjust for the virus. There was no cross-reaction of the sera of these EBO titers rose at the same time or later than titers for the IgM capture ELISA, but they also diminished once peak titers were Results reached. The IFAT titers in 2 of the 3 monkeys who were followed ú400 days fell below titers that would be considered IgG ELISA. The results of the IgG ELISA and the IFAT reliable ( figure 1 ). using sera of experimentally infected primates are illustrated
We also tested the sera of a number of humans who had in figure 1. Detectable levels of IgG antibody were reliably been infected with strains of EBO virus isolated from the 1976 detectable at about days 10 -12. Once the antibodies became epidemic in the Democratic Republic of the Congo (DRC). detectable, the adjusted OD at the 1:100 dilution remained high (ú1.0 OD at 410 nm), and titers remained moderate (800 -The sera from 2 of these individuals were collected Ç10 years after they were infected with EBO. In both instances, the adhad positive ELISA results, but 68 reacted at §1:64 in the IFAT using mixed filoviral antigens. We interpret these results justed OD and titers were similar to those seen in the late convalescent sera of the experimental monkeys (table 1) . Also as being a good indication of the specificity (no false positives) of the ELISA IgG test, not as a lack of sensitivity (false negashown in table 1 are ELISA data that were collected for other individuals in association with the 1976 epidemic in DRC, but tives: IFAT positive, ELISA negative). There were no crossreactions in the ELISA or IFAT of Marburg-or EBO-positive specific time intervals for the collections were not known.
We assessed the specificity of the IgG assay by testing sera sera with the heterologous antigens. Collectively, these data, which were derived from tests on of primates imported under quarantine requirements and which had no evidence of active filoviral infection, as determined by sera of experimental primates and 2 humans, provide strong support for the measurement of long-lasting IgG antibodies IFAT of paired blood samples. from quarantined animals could be interpreted as an indication key, was positive for IgM antibody 28 days following the incident. His serum had an adjusted OD of 1.68 (at 410 nm) of an insensitive test, but when considered with the data mentioned above, it seems more likely that the IFAT-ELISA comat a dilution of 1:100. A subsequent serum sample, obtained 60 days after the above sample, had nearly returned to baseline parison suffers from the lack of specificity reported by others for the IFAT. levels, having an adjusted OD of 0.20 at a 1:100 dilution. IgM ELISA. Figure 3 presents data from an IgM capture assay that was done on sera of experimentally infected monDiscussion keys. Although early sampling was infrequent, these data clearly show that the IgM antibody was acquired early, was
We interpret these data as strong evidence that the IgG ELISA is a specific test, giving adjusted OD values (at 410 measurable by day 6, rose rapidly, peaked by Ç3 weeks, and diminished to undetectable levels by 84 days following infecnm) in excess of 1.0 at 1:100 dilutions of sera from infected primates. Although the number of animals and persons who tion. The test appeared to be specific for antigen prepared from EBO-R because no IgM antibody could be detected using we tested who were known to have been infected was small, the duration of IgG antibody among them was such that the antigens for either EBO-Z or EBO-S (data not shown).
One animal handler, who had been infected following an test holds excellent promise for use as a serologic tool for epidemiologic and epizootiologic investigation of the EBO viaccident during a postmortem examination of an infected mon-/ 9d49$$se36 01-05-99 13:19:00 jinfa UC: J Infect ‡ ? indicates that it was not known when individuals were infected; sera were identified during investigation of DRC outbreak in 1976 but were not from hospital cases who had recovered from disease identified as being EBO virus infection.
ruses. When directly compared, the IgG ELISA showed a patvors might contribute to a high prevalence of IgG antibodies.
Only one human infection with EBO-R was followed; the patern of antibody persistence unlike that for the IFAT: IFAT antibodies waned significantly in the experimental monkeys tient's serum was IgM positive at day 28 and near baseline 2 months later, thus approximating the data available from the who were followed for ú400 days after infection and in the 2 humans whose sera were tested ú10 years after EBO infection, experimental primates. The antibody was specific for the EBO-R, which probably necessitated the use of multiple or mixed whereas the IgG ELISA test was still strongly positive.
IgG antibody levels showed a stronger response to the hoviral antigens in areas where ú1 strain of EBO virus might be suspected as the cause of hemorrhagic fevers. Equivalent remologous viral antigen during early convalescence; however, later, the levels were similar for all 3 strains of viral antigens sults were published recently concerning a patient infected with a new serotype of EBO (subtype Côte d'Ivoire) [25] . Using tested, suggesting that one viral antigen might be suitable for use in screening individuals or populations for past infection antigens obtained from the 3 different EBO subtypes, some cross-reactions were observed with the IFAT and the IgG with any of the known strains of EBO virus.
The IgM capture ELISA also measured significant levels of ELISA, but the IgM capture ELISA was only positive using the homologous antigen. specific IgM in the sera of acutely infected experimental primates and 1 human infected with EBO-R. The antibody became Compared with data from the IFAT, which is used by most measurable in the experimental primates early (6 days) after investigators in previous outbreak and epidemiologic investigainfection, reached appreciable levels by day 10 after infection, tions, these data seem to offer several distinct advantages. First, and did not persist for extended periods, thus making it a good the apparent specificity and enduring sensitivity of the IgG candidate for the diagnosis of incident cases, even in areas ELISA for EBO virus antibodies combine to make the test an with endemic viral infection, where previously infected surviexcellent tool for investigation of the ecology of these viruses. The poor specificity of IFAT antibodies is an impediment in interpreting epidemiologic studies; the availability of a specific and durably sensitive test would greatly facilitate investigation 
